Tandem’s t:Slim X2 insulin pump
Dexcom has partnered with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain. Dexcom’s CGM system, combined with Tandem’s Basal-IQ technology, predicts and prevents hypos while at the same time having no requirement for ‘fingerstick’ calibrations.
Tandem’s t:slim X2 insulin pump with Basal-IQ technology uses Dexcom G6 CGM readings to predict glucose levels 30 minutes ahead and suspend insulin delivery when glucose is predicted to go low. Insulin delivery resumes as soon as sensor glucose values begin to rise. Use of the integrated system reduced the time spent below 3.9 mmol/L (70 mg/dL) by 31% compared to use of a CGM-integrated pump without automated insulin suspension.
Furthermore, with the Dexcom G6 app, users can share their glucose information with up to five people. Whether you are a parent of a child with diabetes or an adult, the Dexcom G6 lets you seamlessly keep track of glucose levels and enables the user’s care team to remotely monitor their loved ones for extra peace of mind.
